Diagnosis and management of primary ciliary dyskinesia

Jane S Lucas1, Andrea Burgess2, Hannah M Mitchison3

  • 1Primary Ciliary Dyskinesia Centre, Southampton Children's Hospital, Southampton NHS Foundation Trust, Southampton, UK Clinical and Experimental Sciences Academic Unit, University of Southampton Faculty of Medicine, Southampton, UK.

Insights

Primary ciliary dyskinesia (PCD) is a genetic disorder affecting motile cilia, causing chronic respiratory issues and other health problems. This review discusses diagnostic challenges and future genetic testing for PCD patients.

Area of Science:

  • Genetics
  • Pulmonology
  • Otolaryngology

Background:

  • Primary ciliary dyskinesia (PCD) is an inherited autosomal-recessive disorder affecting motile cilia.
  • It leads to chronic lung disease, rhinosinusitis, hearing impairment, subfertility, and often bronchiectasis by adulthood.
  • Organ laterality defects, such as situs inversus, occur in approximately 50% of cases.

Purpose of the Study:

  • To review current diagnostic testing referrals for Primary ciliary dyskinesia (PCD).
  • To discuss limitations of existing diagnostic techniques for PCD.
  • To explore the potential of genetic testing and screening for future PCD diagnosis and management.

Main Methods:

  • Literature review of diagnostic criteria and current practices for PCD.
  • Analysis of recent advances in genetic research related to PCD.
  • Discussion of clinical challenges in managing PCD-related respiratory and ENT conditions.

Main Results:

  • Current diagnostic methods for PCD have limitations.
  • Genetic testing holds promise for improving PCD diagnosis and screening.
  • Effective monitoring and treatment of respiratory and ENT issues in children with PCD remain challenging.

Conclusions:

  • Referral for PCD diagnostic testing should be considered in individuals with characteristic symptoms.
  • Advances in genetic analysis may soon facilitate more accurate and widespread PCD diagnosis.
  • Integrated management strategies are crucial for addressing the multifaceted health impacts of PCD in children.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
657
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
5.4K